Top

Serum Institute Seeks Permission For Another Corona Vaccine 'Covovax'

Serum CEO Adar Poonawalla said that an agreement has been made with the Novavax company for the covovax vaccine. Till date the results of this test have been found satisfactory.

Yogita S.

Yogita S.By Yogita S.

Published on 31 Jan 2021 6:00 AM GMT

Serum Institute Seeks Permission For Another Corona Vaccine Covovax
X
COVID VACCINE
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print

New Delhi: Many vaccines are now coming to relieve the corona virus. The Pune-based Serum Institute of India has sought permission from the Government of India to test for one of these vaccines.

On Saturday, Serum CEO Adar Poonawalla said that an agreement has been made with the Novavax company for the covovax vaccine. Till date the results of this test have been found satisfactory. Therefore, permission for its testing in India is sought from the Central Government.

Permit for Covavax:

For this, an application has been given by the company. At the same time, a senior official of the Drug Controller General of India said that the application received from the serum. It was considered by the expert committee (SEC) in the meeting only last week, but the test results were not present during that time.

Therefore, the serum has asked for complete information about the test in Britain. Further decision can be taken only after reviewing this information.

ALSO READ: Coronavirus Update: India’s COVID-19 tally climbs to 1,07,46,183

89.3 percent effective covovax:

There have been human trials of the covovax vaccine in the UK, with 89.3 per cent effect. Serum CEO Adar Poonawalla says that if he gets permission to test it in India soon. Another vaccine will be available with the country by June. Serum has tied up with Novavax company for 200 million doses.

Earlier, the Serum Institute of India had also tied up with the company AstraZenca. On which the covishield vaccine was prepared after testing in India. Recently, the government started a vaccination campaign on 16 January with the indigenous vaccine covaxin after taking doses of 1.1 crore covishield vaccines.

ALSO READ: Centre allows 100% occupancy at cinema halls; Ministry of I&B issues guidelines

Amid vaccinations, gynecologists have advised that women should not plan for a child for at least two months after getting vaccinated. WHO has stated that some vaccines may not be safe for pregnant people.

Gynecologist Dr. Suman Singh of Rainbow Children's Hospital in Hyderabad said that if a woman is getting vaccinated, avoid pregnancy for at least two months. The European Society of Human Reproduction and Embryology affirms this.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.

Yogita S.

Yogita S.

Media Graduate, News Editor and PR Enthusiast.

Next Story